Suppliers and packagers for DIPROLENE

DIPROLENE

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant	Tradename	Generic Name	Dosage	NDA	NDA/ANDA	Supplier	Package Code	Package	Marketing Start
Organon	DIPROLENE	betamethasone dipropionate	OINTMENT, AUGMENTED;TOPICAL	018741	NDA AUTHORIZED GENERIC	Prasco Laboratories	66993-897-15	1 TUBE in 1 BOX (66993-897-15) / 15 g in 1 TUBE	2021-06-01
Organon	DIPROLENE	betamethasone dipropionate	OINTMENT, AUGMENTED;TOPICAL	018741	NDA AUTHORIZED GENERIC	Prasco Laboratories	66993-897-49	1 TUBE in 1 BOX (66993-897-49) / 50 g in 1 TUBE	2021-06-01
Organon	DIPROLENE	betamethasone dipropionate	OINTMENT, AUGMENTED;TOPICAL	018741	NDA	Organon LLC	78206-124-01	1 TUBE in 1 BOX (78206-124-01) / 15 g in 1 TUBE	2021-06-01
Organon	DIPROLENE	betamethasone dipropionate	OINTMENT, AUGMENTED;TOPICAL	018741	NDA	Organon LLC	78206-124-02	1 TUBE in 1 BOX (78206-124-02) / 50 g in 1 TUBE	2021-06-01

Suppliers for the Pharmaceutical Drug: DIPROLENE

Last updated: July 29, 2025

Introduction

DIPROLENE (also known as Diprolene AF) is a topical corticosteroid primarily prescribed for the treatment of inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses. As a potent anti-inflammatory agent, its manufacturing and supply chain are critical to ensuring consistent patient access, regulatory compliance, and market stability. This article explores the key suppliers involved in the production of DIPROLENE, including active pharmaceutical ingredient (API) manufacturers, formulation specialists, and distribution channels, providing a comprehensive overview tailored for industry stakeholders.

Overview of DIPROLENE and Its Composition

DIPROLENE contains betamethasone dipropionate, a synthetic corticosteroid with potent anti-inflammatory properties. It is formulated as a topical cream, gel, or ointment, which mandates a multi-tiered supply chain involving raw material procurement, API synthesis, formulation development, and packaging.

Active Pharmaceutical Ingredient (API) Suppliers

Betamethasone Dipropionate Manufacturing

The core component, betamethasone dipropionate, is synthesized through complex chemical processes requiring specialized chemical manufacturing capabilities. The primary API suppliers are often multinational pharmaceutical companies with robust research and manufacturing infrastructure.

Major API Suppliers

• Sun Pharmaceutical Industries Ltd.
  A leading manufacturer of corticosteroid APIs, Sun Pharma supplies betamethasone dipropionate to various pharmaceutical companies globally. With facilities compliant with Good Manufacturing Practices (GMP), Sun Pharma’s API quality is recognized in regulatory submissions.

• Meda Pharmaceuticals (a part of Mylan/NexGen)
  Meda specializes in corticosteroid APIs, offering high-quality betamethasone dipropionate for formulators seeking reliable supply chains.

• Mylan (now part of Viatris)
  Mylan’s extensive manufacturing footprint includes the production of corticosteroid APIs, including betamethasone derivatives supplied to multiple generic and branded drug manufacturers.

• Intas Pharmaceuticals
  An India-based manufacturer with GMP-certified facilities, Intas supplies corticosteroid APIs to markets across Asia, Africa, and Europe.

• Sandoz (Novartis division)
  Sandoz produces corticosteroids, leveraging their global manufacturing networks to supply APIs for dermatological products like DIPROLENE.

Supply Chain Considerations

The API manufacturing process requires sophisticated chemical synthesis, controlled environments, and strict quality assurance protocols to meet regulatory standards such as USP, EP, and JP. Disruptions in API supply—be it due to raw material shortages, regulatory issues, or manufacturing delays—can significantly impact DIPROLENE availability worldwide.

Formulation and Packaging Suppliers

Topical Formulation Specialists

Once the API is secured, the formulation process involves blending betamethasone dipropionate with excipients, preservatives, and stabilizers to produce stable topical preparations. Major contract manufacturers and pharmaceutical companies involved in this phase include:

• Mylan
  Their formulation units produce DIPROLENE cream and ointment options distributed globally.

• Galenica AG
  A Swiss contract manufacturer known for dermatological formulations, including corticosteroid-based products.

• Hovione
  Specializes in formulation development, ensuring stability, bioavailability, and patient compliance factors.

Packaging and Distribution

Packaging suppliers ensure the stability and safety of DIPROLENE products through high-quality containers, labels, and safety seals. Key players include:

• Nestlé Packaging Division
  Provides blister packs, tubes, and dispensing containers adhering to pharmaceutical standards.

• Gerresheimer
  Known for producing pharmaceutical glass and plastic packaging, supporting the safe delivery of topical corticosteroids.

Distribution Channels and Market Access

Distribution of DIPROLENE involves multiple layers, including wholesale distributors, specialty pharmacies, and hospital supply chains. Major distribution companies include:

• McKesson Corporation
  A primary distributor for dermatological pharmaceuticals across North America.

• AmerisourceBergen
  Provides extensive distribution services supporting pharmaceutical supply chains globally.

• Henry Schein
  Focuses on dental and dermatological products, facilitating access in healthcare settings.

The global availability of DIPROLENE depends on partnerships with these distributors, regulatory approvals across jurisdictions, and adherence to pharmacovigilance standards.

Regulatory and Quality Oversight

Suppliers must comply with regulatory frameworks such as the FDA (U.S.), EMA (Europe), PMDA (Japan), and other national agencies, ensuring Good Manufacturing Practices (GMP) and Good Laboratory Practices (GLP). This oversight guarantees that all suppliers deliver safe, efficacious, and high-quality products.

Market Dynamics and Competitive Landscape

The supply chain for DIPROLENE faces competition from generic corticosteroid formulations and emerging biosimilar products. Manufacturers investing in API innovation and formulation optimization maintain competitive advantages. Recent trends also emphasize sustainable manufacturing practices, quality assurance, and supply chain resilience.

Key Challenges in Supply Chain

• Raw Material Availability: Fluctuations in raw chemical supply can cause delays.
• Regulatory Barriers: Different regional requirements impact API sourcing.
• Manufacturing Capacity: Capacity constraints during global crises (e.g., COVID-19) impair supply.
• Price Fluctuations: Volatility in raw material costs affects margins and procurement strategies.

Future Outlook

Emerging manufacturing technologies, such as continuous manufacturing and process intensification, are expected to enhance API production scalability and consistency. Strategic partnerships and vertical integration may also mitigate supply disruptions. Regulatory harmonization and improved supply chain transparency are pivotal for uninterrupted DIPROLENE availability.

Key Takeaways

• API sourcing is predominantly from established manufacturers like Sun Pharma, Mylan, and Sandoz, emphasizing strict adherence to GMP standards.
• Formulation and packaging involve specialized units ensuring product stability and regulatory compliance.
• Distribution networks are critical to ensuring global access, with major players facilitating supply through extensive logistics.
• Market dynamics continue to evolve, influenced by regulatory standards, raw material stability, and technological advancements.
• Supply chain resilience remains the cornerstone for sustained availability of DIPROLENE amid global health challenges.

FAQs

1. Who are the primary API suppliers for betamethasone dipropionate used in DIPROLENE?
Major API suppliers include Sun Pharmaceutical Industries, Mylan, Sandoz, Meda Pharmaceuticals, and Intas Pharmaceuticals, all adhering to GMP standards to ensure quality and supply consistency.

2. How does the supply chain impact the availability of DIPROLENE globally?
Any disruption—whether from raw material shortages, regulatory issues, or manufacturing delays—can lead to shortages, impacting patient access and prescribing practices.

3. Are there regional differences in suppliers for DIPROLENE?
Yes. Suppliers vary by region, with Indian and Chinese manufacturers supplying raw materials and finished formulations to markets across North America, Europe, and Asia, contingent on regional regulatory approvals.

4. What role do formulation specialists play in the DIPROLENE supply chain?
They convert raw API into stable topical formulations, ensuring efficacy, safety, and patient compliance. They also oversee packaging and labeling essential for regulatory compliance.

5. How might future technological innovations affect DIPROLENE supply?
Advances such as continuous manufacturing and improved process control could enhance capacity, reduce costs, and improve supply chain robustness, ensuring more reliable patient access.

References

1. U.S. Pharmacopeia (USP). Betamethasone Dipropionate Monograph.
2. European Pharmacopoeia (EP). Corticosteroids Standards.
3. Sun Pharmaceutical Industries Ltd. Annual Reports.
4. Mylan/NexGen Corporate Publications.
5. Sandoz Product Portfolio Documentation.